Cannabinoids as hippocampal network administrators
- 1 September 2017
- journal article
- review article
- Published by Elsevier BV in Neuropharmacology
- Vol. 124, 25-37
- https://doi.org/10.1016/j.neuropharm.2017.04.003
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Institute on Drug Abuse
- Intramural Research Program
- Finding a Cure for Epilepsy and Seizures Foundation
This publication has 100 references indexed in Scilit:
- Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5‐HT2A) receptor activity via ERK1/2 signalingSynapse, 2012
- Gamma synchrony: Towards a translational biomarker for the treatment-resistant symptoms of schizophreniaNeuropharmacology, 2012
- A neoHebbian framework for episodic memory; role of dopamine-dependent late LTPTrends in Neurosciences, 2011
- Δ9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampusNeuropharmacology, 2010
- Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations.Behavioral Neuroscience, 2009
- Activation of Cannabinoid-1 Receptors Disrupts Sensory Gating and Neuronal Oscillation: Relevance to SchizophreniaBiological Psychiatry, 2008
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008
- Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates othersNeuropharmacology, 2008
- The Endocannabinoid System Controls Key Epileptogenic Circuits in the HippocampusNeuron, 2006
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994